We are live on ! Find out more
SCS

Syquant Capital SAS Portfolio holdings

AUM $447M
1-Year Est. Return 13.04%
This Fund
S&P 500
This Quarter Est. Return
+63.31%
1 Year Est. Return
+13.04%
3 Year Est. Return
+175.6%
5 Year Est. Return
+350.63%
10 Year Est. Return
–
AUM
$194M
AUM Growth
-$171M
Cap. Flow
-$209M
Cap. Flow %
-107.81%
Top 10 Hldgs %
93.58%
Holding
30
New
13
Increased
2
Reduced
–
Closed
14

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$33.7M
2
BOLD
Audentes Therapeutics, Inc
BOLD
+$28.8M
3
TGE
Tallgrass Energy, LP Class A Shares
TGE
+$18.7M
4
CY
Cypress Semiconductor
CY
+$18.3M
5
TECD
Tech Data Corp
TECD
+$13.2M

Top Sells

Rank Stock Value
1
MDSO
Medidata Solutions, Inc.
MDSO
+$142M
2
CELG
Celgene Corp
CELG
+$61.5M
3
BN icon
Brookfield
BN
+$58.2M
4
GWR
Genesee & Wyoming Inc.
GWR
+$50.7M
5
AABA
Altaba Inc
AABA
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 40.99%
2 Technology 17%
3 Energy 11.08%
4 Industrials 6.68%
5 Utilities 0.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOLD
1
DELISTED
Audentes Therapeutics, Inc
BOLD
$45.9M 23.65%
+767,502
New +$28.8M
MDCO
2
DELISTED
Medicines Co
MDCO
$42.9M 22.09%
+505,030
New +$33.7M
TGE
3
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$21.5M 11.08%
+972,449
New +$18.7M
CY
4
DELISTED
Cypress Semiconductor
CY
$18.3M 9.4%
+782,500
New +$18.3M
TECD
5
DELISTED
Tech Data Corp
TECD
$14.8M 7.6%
+102,755
New +$13.2M
ARQL
6
DELISTED
Arqule Inc
ARQL
$12.4M 6.37%
+619,800
New +$7.19M
AGN
7
DELISTED
Allergan plc
AGN
$10.6M 5.46%
+55,500
New +$10M
RARX
8
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$6.09M 3.13%
+129,690
New +$5.73M
TOO
9
DELISTED
Teekay Offshore Partners L.P.
TOO
$4.69M 2.42%
+3,047,400
New +$4.69M
DBVT
10
DBV Technologies
DBVT
$870M
$4.6M 2.37%
+43,000
New +$3.44M
OMN
11
DELISTED
OMNOVA Solutions Inc.
OMN
$4.31M 2.22%
426,257
– –
WAIR
12
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$3.98M 2.05%
360,992
+104,143
+41% +$1.15M
BMY.RT
13
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.96M 1.01%
+652,486
New +$1.7M
TIF
14
DELISTED
Tiffany & Co.
TIF
$1.44M 0.74%
+10,800
New +$1.28M
TERP
15
DELISTED
TerraForm Power, Inc
TERP
$391K 0.2%
25,400
+8,200
+48% +$132K
DPLO
16
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$377K 0.19%
+94,260
New +$443K
BN icon
17
Brookfield
BN
$107B
– –
-3,070,893
Closed -$58.2M
CLX icon
18
Clorox
CLX
$11.6B
– –
-37,400
Closed -$5.68M
INTU icon
19
Intuit
INTU
$79.6B
– –
-21,600
Closed -$5.74M
TCOM icon
20
Trip.com Group
TCOM
$26.7B
– –
-80,000
Closed -$2.34M
GWR
21
DELISTED
Genesee & Wyoming Inc.
GWR
– –
-458,618
Closed -$50.7M
ONCE
22
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-20,587
Closed -$2M
MCRN
23
DELISTED
Milacron Holdings Corp.
MCRN
– –
-17,211
Closed -$287K
CVRS
24
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
– –
-113,745
Closed -$487K
MDSO
25
DELISTED
Medidata Solutions, Inc.
MDSO
– –
-1,550,606
Closed -$142M
1
2

Similar funds

PT
Plimoth Trust Plymouth, Massachusetts $447M AUM 24.12% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $448M AUM 21.79% 1-Year Est. Return
PC
Peavine Capital Reno, Nevada $446M AUM 7.66% 1-Year Est. Return
AIS
American Investment Services Great Barrington, Massachusetts $448M AUM 21.7% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $446M AUM 13.55% 1-Year Est. Return
FTA
Financial & Tax Architects St Louis, Missouri $448M AUM 13.98% 1-Year Est. Return
GC
Guidance Capital Lousville, Kentucky $446M AUM 19.83% 1-Year Est. Return
POEH
Post Oak Energy Holdings Houston, Texas $449M AUM 53.94% 1-Year Est. Return

Syquant Capital SAS's Q4 2019 Portfolio in Review

As of Q4 2019, Syquant Capital SAS held 30 positions worth $194M, down 47% from $365M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Syquant Capital SAS withdrew a net $209M in Q4 2019, closing 14 positions. Its most notable exit was Medidata Solutions, Inc., an estimated $142M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 17% a quarter earlier, followed by Technology and Energy.

Against the trend, Syquant Capital SAS opened a new position in Medicines Co worth $42.9M.

  • Syquant Capital SAS's largest Q4 2019 buy was Medicines Co: 505,030 shares worth $42.9M.
  • Syquant Capital SAS added most to WESCO Aircraft Holdings Inc. in Q4 2019, an estimated $1.15M increase.
  • Syquant Capital SAS fully exited Medidata Solutions, Inc. in Q4 2019, selling an estimated $142M.
  • Syquant Capital SAS's ten largest holdings make up 94% of its $194M portfolio in Q4 2019.
  • Syquant Capital SAS opened 13 new positions and closed 14 in Q4 2019.
  • Syquant Capital SAS's portfolio value fell 47% quarter-over-quarter to $194M.

Based on Syquant Capital SAS's 13F filing for Q4 2019, filed 8 Jan 2020.